UBS Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $806K | Buy |
88,333
+12,968
| +17% | +$118K | ﹤0.01% | 4507 |
|
|
2025
Q1 | $599K | Sell |
75,365
-87,525
| -54% | -$696K | ﹤0.01% | 4556 |
|
|
2024
Q4 | $884K | Sell |
162,890
-4,546
| -3% | -$24.7K | ﹤0.01% | 4305 |
|
|
2024
Q3 | $1.21M | Buy |
167,436
+27,873
| +20% | +$201K | ﹤0.01% | 3446 |
|
|
2024
Q2 | $1.52M | Sell |
139,563
-115,663
| -45% | -$1.26M | ﹤0.01% | 3072 |
|
|
2024
Q1 | $4.78M | Buy |
255,226
+52,022
| +26% | +$975K | ﹤0.01% | 2233 |
|
|
2023
Q4 | $4.4M | Buy |
203,204
+100,465
| +98% | +$2.18M | ﹤0.01% | 2118 |
|
|
2023
Q3 | $2.11M | Buy |
102,739
+22,358
| +28% | +$460K | ﹤0.01% | 2507 |
|
|
2023
Q2 | $3.78M | Buy |
80,381
+498
| +0.6% | +$23.4K | ﹤0.01% | 2134 |
|
|
2023
Q1 | $3.35M | Sell |
79,883
-21,896
| -22% | -$919K | ﹤0.01% | 2158 |
|
|
2022
Q4 | $3.88M | Buy |
101,779
+81,310
| +397% | +$3.1M | ﹤0.01% | 2037 |
|
|
2022
Q3 | $801K | Sell |
20,469
-54,292
| -73% | -$2.12M | ﹤0.01% | 3014 |
|
|
2022
Q2 | $2.42M | Sell |
74,761
-57,717
| -44% | -$1.86M | ﹤0.01% | 2261 |
|
|
2022
Q1 | $4.39M | Sell |
132,478
-1,691
| -1% | -$56K | ﹤0.01% | 2026 |
|
|
2021
Q4 | $5.71M | Buy |
134,169
+36,169
| +37% | +$1.54M | ﹤0.01% | 1979 |
|
|
2021
Q3 | $4.34M | Buy |
98,000
+70,887
| +261% | +$3.14M | ﹤0.01% | 2131 |
|
|
2021
Q2 | $1.54M | Sell |
27,113
-4,742
| -15% | -$269K | ﹤0.01% | 2931 |
|
|
2021
Q1 | $2.38M | Buy |
31,855
+20,378
| +178% | +$1.53M | ﹤0.01% | 2617 |
|
|
2020
Q4 | $993K | Sell |
11,477
-10,390
| -48% | -$899K | ﹤0.01% | 3171 |
|
|
2020
Q3 | $1.34M | Sell |
21,867
-38,660
| -64% | -$2.36M | ﹤0.01% | 2735 |
|
|
2020
Q2 | $2.52M | Buy |
60,527
+45,934
| +315% | +$1.91M | ﹤0.01% | 2102 |
|
|
2020
Q1 | $420K | Buy |
14,593
+3,369
| +30% | +$97K | ﹤0.01% | 3358 |
|
|
2019
Q4 | $810K | Sell |
11,224
-5,970
| -35% | -$431K | ﹤0.01% | 3513 |
|
|
2019
Q3 | $2.41M | Sell |
17,194
-10,087
| -37% | -$1.42M | ﹤0.01% | 2468 |
|
|
2019
Q2 | $5M | Sell |
27,281
-3,751
| -12% | -$687K | ﹤0.01% | 1818 |
|
|
2019
Q1 | $4.94M | Sell |
31,032
-15,771
| -34% | -$2.51M | ﹤0.01% | 1774 |
|
|
2018
Q4 | $4.48M | Buy |
46,803
+26,726
| +133% | +$2.56M | ﹤0.01% | 1782 |
|
|
2018
Q3 | $2.84M | Buy |
20,077
+6,084
| +43% | +$859K | ﹤0.01% | 2331 |
|
|
2018
Q2 | $2.19M | Sell |
13,993
-9,500
| -40% | -$1.49M | ﹤0.01% | 2476 |
|
|
2018
Q1 | $3.79M | Buy |
23,493
+16,636
| +243% | +$2.68M | ﹤0.01% | 2070 |
|
|
2017
Q4 | $1.13M | Sell |
6,857
-12,707
| -65% | -$2.09M | ﹤0.01% | 2945 |
|
|
2017
Q3 | $1.22M | Buy |
19,564
+7,633
| +64% | +$475K | ﹤0.01% | 2856 |
|
|
2017
Q2 | $950K | Sell |
11,931
-8,810
| -42% | -$701K | ﹤0.01% | 2954 |
|
|
2017
Q1 | $1.48M | Sell |
20,741
-11,715
| -36% | -$833K | ﹤0.01% | 2561 |
|
|
2016
Q4 | $1.66M | Buy |
32,456
+32,194
| +12,288% | +$1.64M | ﹤0.01% | 2429 |
|
|
2016
Q3 | $12K | Sell |
262
-16,912
| -98% | -$775K | ﹤0.01% | 5751 |
|
|
2016
Q2 | $518K | Buy |
17,174
+15,368
| +851% | +$464K | ﹤0.01% | 3123 |
|
|
2016
Q1 | $58K | Sell |
1,806
-28,268
| -94% | -$908K | ﹤0.01% | 4597 |
|
|
2015
Q4 | $1.75M | Buy |
30,074
+29,774
| +9,925% | +$1.74M | ﹤0.01% | 2282 |
|
|
2015
Q3 | $13K | Sell |
300
-29
| -9% | -$1.26K | ﹤0.01% | 5765 |
|
|
2015
Q2 | $24K | Buy |
329
+29
| +10% | +$2.12K | ﹤0.01% | 5363 |
|
|
2015
Q1 | $15K | Sell |
300
-341
| -53% | -$17.1K | ﹤0.01% | 5610 |
|
|
2014
Q4 | $23K | Buy |
+641
| New | +$23K | ﹤0.01% | 5388 |
|